← Back to Search

Behavioral Intervention

Group 1: SPOT-ON for Shortness of Breath

Phase 2 & 3

Waitlist Available

Led By David Hui, MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up [time frame: through study completion; an average of 1 year.]

Awards & highlights

Study Summary

"This trial aims to study how a personalized oxygen treatment called SPOT-ON can help cancer patients with shortness of breath."

Who is the study for?

This trial is for cancer patients experiencing shortness of breath. Specific eligibility details are not provided, but typically participants must meet certain health conditions to join.Check my eligibility

What is being tested?

The study tests the SPOT-ON treatment's impact on easing shortness of breath in cancer patients. It compares two groups: one starts treatment early (Early Start), and the other later (Delayed Start).See study design

What are the potential side effects?

Potential side effects are not detailed, but may include reactions related to oxygen therapy or supportive treatments used in managing dyspnea in oncology patients.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ [time frame: through study completion; an average of 1 year.]

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~[time frame: through study completion; an average of 1 year.]

This trial's timeline: 3 weeks for screening, Varies for treatment, and [time frame: through study completion; an average of 1 year.] for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Measure: 1.Safety and adverse events (AEs)

Trial Design

2Treatment groups

Experimental Treatment

Group I: Group 2: SPOT-ON WaitlistExperimental Treatment2 Interventions

Participants will work with the healthcare team to find the best ways to reduce your shortness of breath by finding what combination of treatments work for participant. Participants will receive education about shortness of breath by the research staff in addition to information about standard treatments or medications for your shortness of breath that would be offered by your medical team.

Group II: Group 1: SPOT-ONExperimental Treatment2 Interventions

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,975 Previous Clinical Trials

1,789,359 Total Patients Enrolled

David Hui, MDPrincipal InvestigatorM.D. Anderson Cancer Center

16 Previous Clinical Trials

101,390 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"As per clinicaltrials.gov, recruitment for this investigation is presently closed. The trial information was initially posted on September 30th, 2024 and most recently updated on March 20th, 2024. While this specific study is not actively seeking participants currently, there are a total of 48 other trials open for patient enrollment at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

2024. "Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06336642.

~100 spots leftby Mar 2030

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.